Management can control the operation cost and the market is well aware of the very high salary cost, especially this quarter. Whether they are once-off/start-up expense, we don't even know and that's why the pps is still below 5c even after this good news. IMO, they tried to expand way too fast.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-69
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |